Fund shareholders of Palvella Therapeutics Inc
ISIN US6979471090 · United States · LEI 254900AJDH8PAOOI5T33
- Fund shareholders
- 171
- Of which ETFs
- 27 144 other funds
- Value held
- 478.5M $
- Share of capital
- 26.1 % of 14.4M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 361,690 | 45.1M $ | 0.00 % | 2.51 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 276,556 | 35.5M $ | 0.76 % | 1.92 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 274,232 | 34.2M $ | 0.46 % | 1.90 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 231,484 | 28.9M $ | 1.82 % | 1.61 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 189,480 | 23.6M $ | 0.03 % | 1.32 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 183,037 | 24.7M $ | 1.69 % | 1.27 % | as of Feb 27, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 176,675 | 22.7M $ | 0.33 % | 1.23 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 153,120 | 19.1M $ | 0.18 % | 1.06 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 150,500 | 19.3M $ | 0.67 % | 1.04 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 129,440 | 16.6M $ | 0.20 % | 0.90 % | as of Apr 30, 2026 ↗ |
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 120,586 | 15M $ | 0.56 % | 0.84 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 110,845 | 14.2M $ | 0.49 % | 0.77 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 103,470 | 12.9M $ | 0.02 % | 0.72 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 81,883 | 10.2M $ | 0.08 % | 0.57 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 76,768 | 9.9M $ | 0.03 % | 0.53 % | as of Apr 30, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 71,816 | 9.2M $ | 0.39 % | 0.50 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 65,580 | 8.4M $ | 0.20 % | 0.46 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 59,134 | 7.4M $ | 0.06 % | 0.41 % | as of Mar 31, 2026 ↗ |
| ClearBridge Small Cap Fund Legg Mason Global Asset Management Trust | 56,480 | 7.2M $ | 0.99 % | 0.39 % | as of Apr 30, 2026 ↗ |
| PGIM Jennison Small Company Fund Prudential Jennison Small Co Fund, Inc. | 53,271 | 6.6M $ | 0.21 % | 0.37 % | as of Mar 31, 2026 ↗ |
| Emerald Growth Fund FINANCIAL INVESTORS TRUST | 52,070 | 6.7M $ | 0.47 % | 0.36 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 46,729 | 5.8M $ | 0.07 % | 0.32 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 40,332 | 5.4M $ | 0.01 % | 0.28 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 35,837 | 4.8M $ | 0.03 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Calamos Timpani Small Cap Growth Fund CALAMOS INVESTMENT TRUST/IL | 31,895 | 4.1M $ | 0.55 % | 0.22 % | as of Apr 30, 2026 ↗ |
| Neuberger Small Cap Growth Fund NEUBERGER BERMAN EQUITY FUNDS | 26,116 | 3.5M $ | 0.73 % | 0.18 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 23,095 | 3.1M $ | 0.02 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Small Cap Core Portfolio Bernstein Fund Inc | 21,576 | 2.7M $ | 0.38 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 20,783 | 2.7M $ | 0.24 % | 0.14 % | as of Apr 30, 2026 ↗ |
| JNL Multi-Manager Small Cap Growth Fund JNL Series Trust | 20,757 | 2.6M $ | 0.13 % | 0.14 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 19,546 | 2.4M $ | 0.20 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 19,500 | 2.4M $ | 1.35 % | 0.14 % | as of Mar 31, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 19,093 | 2.6M $ | 0.18 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 17,236 | 2.3M $ | 0.60 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 17,029 | 2.2M $ | 0.03 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 16,700 | 2.3M $ | 0.04 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 15,705 | 2M $ | 0.39 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 14,700 | 2M $ | 0.00 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 11,885 | 1.5M $ | 0.03 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 11,743 | 1.6M $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 11,110 | 1.4M $ | 0.00 % | 0.08 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 10,552 | 1.4M $ | 1.03 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 10,185 | 1.3M $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Victory Small Cap Stock Fund Victory Portfolios III | 9,944 | 1.3M $ | 0.14 % | 0.07 % | as of Apr 30, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 9,678 | 1.2M $ | 1.26 % | 0.07 % | as of Apr 30, 2026 ↗ |
| M Capital Appreciation Fund M FUND INC | 9,479 | 1.2M $ | 0.45 % | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 9,427 | 1.2M $ | 0.18 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Carillon Chartwell Small Cap Fund Carillon Series Trust | 9,313 | 1.2M $ | 0.61 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 9,277 | 1.2M $ | 0.03 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Alger Dynamic Opportunities Fund ALGER FUNDS II | 9,233 | 1.2M $ | 0.53 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Calamos Growth Fund CALAMOS INVESTMENT TRUST/IL | 8,369 | 1.1M $ | 0.06 % | 0.06 % | as of Apr 30, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 8,114 | 1M $ | 0.03 % | 0.06 % | as of Mar 31, 2026 ↗ |
| ALGER SMALL CAP GROWTH FUND ALGER FUNDS | 8,035 | 1M $ | 0.54 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 7,742 | 1M $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Knights of Columbus Small Cap Equity Fund ADVISORS' INNER CIRCLE III | 6,958 | 892.9K $ | 0.46 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 6,457 | 804.9K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 6,197 | 836.7K $ | 0.06 % | 0.04 % | as of Feb 28, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 6,093 | 759.5K $ | 0.07 % | 0.04 % | as of Mar 31, 2026 ↗ |
| AVIP AB Small Cap Portfolio AuguStar Variable Insurance Products Fund Inc | 6,052 | 754.4K $ | 0.28 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 5,959 | 742.8K $ | 0.79 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 5,926 | 760.4K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Carillon Chartwell Small Cap Growth Fund Carillon Series Trust | 5,781 | 720.6K $ | 0.56 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Alger Small Cap Growth Portfolio ALGER PORTFOLIOS | 5,769 | 719.1K $ | 0.55 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 5,621 | 700.7K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 5,506 | 686.3K $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 5,360 | 668.1K $ | 0.45 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 5,310 | 661.9K $ | 0.02 % | 0.04 % | as of Mar 31, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 4,900 | 610.8K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 4,860 | 623.6K $ | 0.34 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 4,772 | 612.3K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 4,643 | 578.7K $ | 0.06 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 4,496 | 576.9K $ | 0.02 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 4,475 | 604.2K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 3,976 | 495.6K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF Goldman Sachs ETF Trust | 3,963 | 535.1K $ | 0.06 % | 0.03 % | as of Feb 28, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 3,940 | 491.1K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 3,669 | 457.3K $ | 0.07 % | 0.03 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 3,492 | 435.3K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 3,488 | 434.8K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 3,373 | 420.4K $ | 0.19 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 3,330 | 427.3K $ | 0.03 % | 0.02 % | as of Apr 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 3,312 | 412.8K $ | 0.08 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 3,265 | 419K $ | 0.02 % | 0.02 % | as of Apr 30, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 3,078 | 395K $ | 0.04 % | 0.02 % | as of Apr 30, 2026 ↗ |
| PACE Small/Medium Co Growth Equity Investments PACE SELECT ADVISORS TRUST | 3,069 | 393.8K $ | 0.16 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 3,008 | 374.9K $ | 0.11 % | 0.02 % | as of Mar 31, 2026 ↗ |
| ALGER SMALL CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 2,998 | 384.7K $ | 0.54 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 2,798 | 359K $ | 0.96 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 2,794 | 377.2K $ | 0.03 % | 0.02 % | as of Feb 28, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 2,700 | 336.6K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Invesco V.I. Health Care Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 2,691 | 335.4K $ | 0.23 % | 0.02 % | as of Mar 31, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 2,572 | 320.6K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 2,510 | 312.9K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 2,375 | 296K $ | 0.19 % | 0.02 % | as of Mar 31, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 2,269 | 282.8K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 2,158 | 269K $ | 0.56 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 2,146 | 267.5K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 2,030 | 253K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| WCM Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST | 2,014 | 251K $ | 0.53 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 1,943 | 242.2K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.82 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 1.69 % | as of Feb 27, 2026 ↗ |
| LISANTI SMALL CAP GROWTH FUND FORUM FUNDS | 1.41 % | as of Mar 31, 2026 ↗ |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 1.35 % | as of Mar 31, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 1.26 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.03 % | as of Feb 28, 2026 ↗ |
| ClearBridge Small Cap Fund Legg Mason Global Asset Management Trust | 0.99 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.96 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 0.79 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 0.76 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 171 | +41 | 3,762,303 | +37.4 % |
| 2026Q1 | 130 | +33 | 2,737,428 | +49.6 % |
| 2025Q4 | 97 | +38 | 1,830,015 | +144.8 % |
| 2025Q3 | 59 | +51 | 747,483 | +239.2 % |
| 2025Q2 | 8 | +6 | 220,385 | +1,852.6 % |
| 2025Q1 | 2 | 11,287 |
Institutional managers
173 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,153,496 | 143.8M $ | as of Mar 31, 2026 |
| First Light Asset Management, LLC | 980,758 | 122.3M $ | as of Mar 31, 2026 |
| BVF INC/IL | 960,989 | 119.8M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 882,400 | 110M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 686,853 | 85.6M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 640,611 | 79.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 458,999 | 57.2M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 433,015 | 54M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 402,564 | 50.2K $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 374,035 | 46.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 317,517 | 39.6M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 262,835 | 27.5M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 257,485 | 32.1M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 233,248 | 29M $ | as of Mar 31, 2026 |
| FMR LLC | 215,808 | 26.9M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 206,404 | 25.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 205,609 | 25.6M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 195,030 | 24.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 194,179 | 24.2M $ | as of Mar 31, 2026 |
| Artisan Partners Limited Partnership | 193,796 | 24.2M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 179,922 | 22.4M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 161,500 | 20.1M $ | as of Mar 31, 2026 |
| First Turn Management, LLC | 148,093 | 18.5M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 134,600 | 16.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 127,987 | 16M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Palvella Therapeutics Inc". https://titelia.com/en/stocks/palvella-therapeutics-inc-US6979471090